Analystreport

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report